Q2 2023 · 13F-HR
Samsara BioCapital, LLCholdings as filed
Filed 2023-08-14 · accession 0001104659-23-091467
$569.7M
Reported value
47
Positions
2023-06-30
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 16961L106 | — | CHINOOK THERAPEUTICS INC | $198.3M | 34.8% | 5,161,888 | Common | SOLE |
| 603170101 | MLYS | MINERALYS THERAPEUTICS INC | $77.1M | 13.5% | 4,519,361 | Common | SOLE |
| 00445A100 | — | ACELYRIN INC | $47.2M | 8.28% | 2,256,022 | Common | SOLE |
| 80706P103 | SRRK | SCHOLAR ROCK HLDG CORP | $34.7M | 6.09% | 4,598,828 | Common | SOLE |
| 38870X104 | GRPH | GRAPHITE BIO INC | $22.0M | 3.86% | 8,459,314 | Common | SOLE |
| 03940C100 | ACLXGBX | ARCELLX INC | $19.4M | 3.41% | 613,921 | Common | SOLE |
| 05337M104 | — | AVADEL PHARMACEUTICALS PLC | $15.9M | 2.80% | 967,527 | Common | SOLE |
| 98985Y108 | ZYME | ZYMEWORKS INC | $12.6M | 2.21% | 1,458,875 | Common | SOLE |
| 46583P102 | — | IVERIC BIO INC | $12.1M | 2.13% | 308,151 | Common | SOLE |
| 55234L105 | LYRAGBP | LYRA THERAPEUTICS INC | $11.4M | 2.01% | 2,780,261 | Common | SOLE |
| 43157M102 | — | HILLEVAX INC | $10.3M | 1.81% | 599,274 | Common | SOLE |
| 23345J104 | — | DICE THERAPEUTICS INC | $9.4M | 1.65% | 202,773 | Common | SOLE |
| 869367102 | — | SUTRO BIOPHARMA INC | $7.8M | 1.37% | 1,675,579 | Common | SOLE |
| 925050106 | VRNA | VERONA PHARMA PLC | $7.3M | 1.29% | 347,500 | Common | SOLE |
| 00461U105 | ACRS | ACLARIS THERAPEUTICS INC | $7.2M | 1.27% | 696,171 | Common | SOLE |
| 45845P108 | — | INTERCEPT PHARMACEUTICALS IN | $7.1M | 1.24% | 640,688 | Common | SOLE |
| 74168J101 | PRME | PRIME MEDICINE INC | $6.9M | 1.21% | 470,304 | Common | SOLE |
| 65487U108 | NKTX | NKARTA INC | $6.3M | 1.10% | 2,868,035 | Common | SOLE |
| 713317105 | PEPG | PEPGEN INC | $5.8M | 1.02% | 651,050 | Common | SOLE |
| 76243J105 | RYTM | RHYTHM PHARMACEUTICALS INC | $5.7M | 1.00% | 345,293 | Common | SOLE |
| 45258D105 | IMCR | IMMUNOCORE HLDGS PLC | $4.9M | 0.85% | 80,963 | Common | SOLE |
| N44445109 | IMTX | IMMATICS N.V | $4.6M | 0.80% | 396,000 | Common | SOLE |
| 47103J105 | JANX | JANUX THERAPEUTICS INC | $4.3M | 0.75% | 360,414 | Common | SOLE |
| 30233G209 | EYPT | EYEPOINT PHARMACEUTICALS INC | $3.8M | 0.66% | 432,000 | Common | SOLE |
| 24343R106 | — | DECIBEL THERAPEUTICS INC | $3.1M | 0.54% | 801,629 | Common | SOLE |
| 87184Q206 | SYRS | SYROS PHARMACEUTICALS INC | $2.8M | 0.49% | 881,450 | Common | SOLE |
| 75082Q105 | — | RAIN ONCOLOGY INC | $2.4M | 0.43% | 2,034,552 | Common | SOLE |
| 23954D109 | DAWNGBX | DAY ONE BIOPHARMACEUTICALS I | $2.3M | 0.41% | 196,425 | Common | SOLE |
| 87583X109 | TNGX | TANGO THERAPEUTICS INC | $2.1M | 0.37% | 630,000 | Common | SOLE |
| 449778109 | IOBTQ | IO BIOTECH INC | $2.0M | 0.35% | 1,008,437 | Common | SOLE |
| 52187K200 | CYPH | LEAP THERAPEUTICS INC | $1.9M | 0.33% | 602,203 | Common | SOLE |
| 880881107 | 430 | TERNS PHARMACEUTICALS INC | $1.8M | 0.31% | 202,348 | Common | SOLE |
| 449585108 | 1K0 | IGM BIOSCIENCES INC | $1.4M | 0.25% | 154,664 | Common | SOLE |
| 097702104 | BOLT1EUR | BOLT BIOTHERAPEUTICS INC | $1.3M | 0.24% | 1,049,153 | Common | SOLE |
| 28623U101 | — | ELEVATION ONCOLOGY INC | $1.3M | 0.22% | 830,565 | Common | SOLE |
| 918385105 | — | VTV THERAPEUTICS INC | $1.2M | 0.21% | 1,635,509 | Common | SOLE |
| 45783C101 | — | INSTIL BIO INC | $985,342 | 0.17% | 1,788,280 | Common | SOLE |
| 92765F108 | RYI | VIRACTA THERAPEUTICS INC | $972,490 | 0.17% | 689,709 | Common | SOLE |
| 01671P100 | ALLKGUSD | ALLAKOS INC | $750,308 | 0.13% | 172,089 | Common | SOLE |
| 00773J103 | — | AEGLEA BIOTHERAPEUTICS INC | $398,116 | 0.07% | 883,720 | Common | SOLE |
| 019818103 | — | ALLOVIR INC | $279,942 | 0.05% | 82,336 | Common | SOLE |
| 04635X102 | CATBUSD | ASTRIA THERAPEUTICS INC | $208,250 | 0.04% | 25,000 | Common | SOLE |
| 808644108 | — | SCIENCE 37 HOLDINGS INC | $191,250 | 0.03% | 900,000 | Common | SOLE |
| 670002401 | NVAX | NOVAVAX INC | $157,843 | 0.03% | 21,244 | Common | SOLE |
| 50107A104 | KRON1USD | KRONOS BIO INC | $134,385 | 0.02% | 78,131 | Common | SOLE |
| 67080N119 | NUVB/WS | NUVATION BIO INC | $22,052 | 0.00% | 133,333 | Common | SOLE |
| 86889P117 | SRZNW | SURROZEN INC | $5,520 | 0.00% | 99,999 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.